These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6127884)

  • 61. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
    Doering W; Wauer B; Isbary J
    Acta Med Scand Suppl; 1982; 659():307-14. PubMed ID: 6127897
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
    Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
    Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
    Kulling P
    Acta Med Scand Suppl; 1982; 659():191-9. PubMed ID: 6127889
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
    Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
    Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
    [No Abstract]   [Full Text] [Related]  

  • 66. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
    Greefhorst AP; van Herwaarden CL
    Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intravenous prenalterol in acute and chronic heart failure.
    Kirlin PC; Pitt B; Lucchesi BR
    Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
    [No Abstract]   [Full Text] [Related]  

  • 68. Rectosigmoid motility response to beta-adrenoceptor stimulation in patients with the irritable bowel syndrome.
    Lyrenäs E; Abrahamsson H; Dotevall G
    Scand J Gastroenterol; 1985 Dec; 20(10):1163-8. PubMed ID: 2869573
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1984 May; 229(2):340-5. PubMed ID: 6143816
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of prenalterol on renal function in normal man.
    Järnberg PO; Westman L
    Acta Anaesthesiol Scand; 1982 Dec; 26(6):603-6. PubMed ID: 6130667
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beta adrenergic influence on oesophageal peristalsis in man.
    Lyrenäs E; Abrahamsson H
    Gut; 1986 Mar; 27(3):260-6. PubMed ID: 2870956
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure.
    Fitzpatrick D; Ikram H; Nicholls MG; Espiner EA
    Circulation; 1983 Mar; 67(3):613-9. PubMed ID: 6821903
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prenalterol in cardiogenic shock following acute myocardial infarction.
    Coma-Canella I; Lopez-Sendon J; Jadraque LM
    Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
    Waagstein F; Estrada-Yamamoto M; Reiz S; Reyes C; Hjalmarson A
    Acta Med Scand Suppl; 1982; 659():221-31. PubMed ID: 6127891
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
    Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
    Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of a beta 1-adrenoceptor agonist, prenalterol, on renal function and renin secretion rate in anesthetized dogs.
    Johnson MD; Freese JW; Schmitt DE
    J Cardiovasc Pharmacol; 1984; 6(4):627-33. PubMed ID: 6206317
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Electrophysiologic properties of prenalterol.
    Capucci A; Frabetti L; Melandri G; Magnani B
    Int J Cardiol; 1983; 2(3-4):391-400. PubMed ID: 6132888
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.
    Laustiola K; Uusitalo A; Koivula T; Sovijärvi A; Seppälä E; Nikkari T; Vapaatalo H
    Eur J Clin Pharmacol; 1983; 25(3):293-7. PubMed ID: 6628516
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metabolic consequences of salbutamol poisoning reversed by propranolol.
    Corea L; Bentivoglio M; Verdecchia P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6354):1578. PubMed ID: 6128050
    [No Abstract]   [Full Text] [Related]  

  • 80. Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1980 May; 213(2):406-13. PubMed ID: 6102602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.